GEORGIOU GEORGE 4
4 · Aeglea BioTherapeutics, Inc. · Filed Aug 15, 2018
Insider Transaction Report
Form 4
GEORGIOU GEORGE
Director
Transactions
- Exercise/Conversion
Common Stock
2018-08-13$4.73/sh+20,000$94,600→ 175,861 total - Exercise/Conversion
Common Stock
2018-08-13$7.28/sh+17,333$126,184→ 155,861 total - Exercise/Conversion
Director Stock Option (right to buy)
2018-08-13−17,333→ 6,667 totalExercise: $7.28Exp: 2026-05-16→ Common Stock (17,333 underlying) - Exercise/Conversion
Director Stock Option (right to buy)
2018-08-13−20,000→ 10,000 totalExercise: $4.73Exp: 2027-11-30→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]The stock option vested and became exercisable, and shall continue to vest and become exercisable, in 36 equal monthly installments beginning on June 17, 2016, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.
- [F2]The stock option vested and became exercisable, and shall continue to vest and become exercisable, in 12 equal monthly installments beginning on January 1, 2018 until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.